Company Filing History:
Years Active: 2014
Title: Innovations of Xiaohong Qi in Controlled Release Formulations.
Introduction
Xiaohong Qi is an accomplished inventor based in Dave, Florida. She has made significant contributions to the field of pharmaceutical formulations, particularly in controlled release technologies. Her innovative work has led to the development of a unique diltiazem formulation that enhances therapeutic efficacy.
Latest Patents
Xiaohong Qi holds a patent for a controlled release diltiazem dosage formulation. This formulation comprises a plurality of diltiazem pellets and a gel-forming material. Notably, the time of maximum diltiazem blood plasma levels occurs more than 8 hours after administration, and preferably more than 10 hours after administration. This innovation aims to improve patient outcomes by providing a more effective delivery method for diltiazem.
Career Highlights
Xiaohong Qi is currently employed at Andrx Labs, LLC, where she continues to advance her research in pharmaceutical formulations. Her work at Andrx Labs has positioned her as a key player in the development of innovative drug delivery systems. With her expertise, she has contributed to the company's reputation for excellence in the pharmaceutical industry.
Collaborations
Xiaohong has collaborated with notable colleagues, including Xiu Xiu Cheng and Guohua Zhang. These collaborations have fostered a productive research environment, leading to advancements in their respective fields.
Conclusion
Xiaohong Qi's contributions to controlled release formulations exemplify her dedication to innovation in the pharmaceutical industry. Her patent for a diltiazem formulation showcases her ability to enhance drug delivery methods. Through her work at Andrx Labs, she continues to make a significant impact in the field.